Spain urges the EU to place biotechnology at the core of its Industrial Strategy 22/07/2025 Healthcare Climate change Agrifood Industrial biotechnology International Financing At AseBio, we strongly support the proposals put forward by the Minister of Industry and Tourism, which not only reflect... AseBio
Expanding analyst interest in ORYZON 21/07/2025 Healthcare New U.S. investment bank joins, bringing total coverage to ten analysts. Partners - Oryzon Genomics
EHDS: A revolution in health data management 18/07/2025 Healthcare It aims to turn health data into a strategic asset to improve healthcare, accelerate innovation in health technologies... Partners - GENESIS Biomed
#NewAseBioMember | “For us, AseBio is a key platform for connection, visibility, and colla... 16/07/2025 Healthcare Corporate Meet Maieutics Research Solutions, our new member. We talk with Lander Ezequiel Senderowicz, Operational Manager Partners - MAIEUTICS RESEARCH SOLUTIONS
ORYZON continues to strengthen its patent portfolio for vafidemstat 14/07/2025 Healthcare New “Decision to grant” communications in Canada and Israel. For the treatment of aggression and social withdrawal Partners - Oryzon Genomics
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro... 13/07/2025 Healthcare The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special... AseBio - CIBER
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro... 13/07/2025 CIBER The World Health Organization recognizes over 150 different types of sarcomas, a rare disease that poses significant... AseBio - CIBER
ADmit Therapeutics Relocates to New State-of-the-Art Facilities Within the Almirall’s Inn... 03/07/2025 Healthcare Biotech company ADmit Therapeutics has announced its move to new state-of-the-art facilities at “The Hive”, Almirall’s... Partners - ADmit Therapeutics
Webinar “What is needed to progress ATMPs in Europe” Online Del 10/07/2025 13:30 to 10/07/2025 Healthcare Advanced therapies
